Pfizer creates 70 new jobs in stem cell facility launch
This article was originally published in Scrip
Executive Summary
Pfizerhas launched a new research unit to explore the use of stem cells. This comes at a time when many pharmaceutical companies are closing facilities and making sharp staff cuts, but follows a trend towards research into novel biological therapies.